Price loading...

Medicare s Prescription Drug Program: Competition Issues & Cost Trends

Pharmacology

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (generally referred to as the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In fiscal year 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10 percent of net federal spending for Medicare. This book discusses the cost trends and competition issues of Medicare's Prescription Drug Program.

Product Specifications

Format: hardcover
ASIN: 1634631226
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 01 December 2014
Listed Since: 13 September 2014

Barcode

No barcode data available

Medicare s Prescription Drug Program: Competition Issues & Cost Trends

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Medicare Part B: Premiums & High-Expenditure Drugs (Health Care Issues, Costs and Access)

Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)

Prescription Drug Pricing: Cost & Control Concerns (Health Care Issues, Costs and Access)

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

Opioid Use and Misuse in the Medicare System - Nova Science

Improving Medicare (Health Care Issues, Costs and Access)

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

Pharmaceutical Industry: Innovation & Developments (Business Issues, Competition and Entrepreneurship)

Research and Development in the Pharmaceutical Industry

Medicaid Third-Party Liability: Savings Issues & Efforts

Progress in Medical Research: Government Programs and Key Issues (Medical Procedures, Testing and Technology)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Prescription Drug Abuse: Reduction Efforts & Federal Role (Alcohol and Drug Abuse)

Pharmaceutical Public Policy

Medicare, Health Care Delivery & Payment Reform Recommendations (Health Care Issues, Costs & Access Series) (Health Care Issues, Costs and Access)

Medicare: Current Issues and Background

PRESCRIPTION DRUGS (Substance Abuse Assassment Interventions and Treatment)

Pet Medications industry: Overview, Competition & Distribution Issues

Medicaid & Treatment for People with Substance Abuse Problems (Health Care Issues, Costs and Access)

Prescription Drug Prices Paid Under Federal Programs: Analyses, Differences, Factors (Health Care in Transition)

Medicaid Spending by States: Variations & Influences

DUAL ELIGIBLE BENEFICIARIES OF: Characteristics, Costs & Policies (Health Care Issues, Costs and Access)

Medicaid & Long-Term Care Assistance: Financial Eligibility Issues (Health Care in Transition)

HEALTH CARE FRAUD QUESTIONA.: Select Investigations (Health Care Issues, Costs and Access)